IDEAYA Biosciences' clinical trial progress, strong financials, and diversified pipeline signal long-term growth potential ...

Avidity Biosciences ( NASDAQ: RNA) quickly soared 20% after a report that Novartis ( NYSE: NVS) made a takeover approach for the rare-disease maker.

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview Published Feb 14, 2025 7:00am EST ...

--Anixa Biosciences, Inc., a biotechnology company focused on the treatment and prevention of cancer, announced today that it will be participating in the iAccess Alpha Virtual Best Ideas Winter ...

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview PR Newswire SAN JOSE, Calif., Feb. 14, 2025 ...